BioCrossroads Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • BioCrossroads's estimated annual revenue is currently $2.5M per year.(i)
  • BioCrossroads's estimated revenue per employee is $155,000

Employee Data

  • BioCrossroads has 16 Employees.(i)
  • BioCrossroads grew their employee count by 0% last year.

BioCrossroads's People

NameTitleEmail/Phone
1
President/CEOReveal Email/Phone
2
SVP and Chief Strategy Officer | Managing Director Seed FundsReveal Email/Phone
3
SVP, External Engagement & Chief Innovation OfficerReveal Email/Phone
4
VP Communications Reveal Email/Phone
5
VP FinanceReveal Email/Phone
6
EVP Strategy, Managing Director Seed FundReveal Email/Phone
7
Director OperationsReveal Email/Phone
8
Office ManagerReveal Email/Phone
9
Executive AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M5-17%N/AN/A
#2
$5.7M376%N/AN/A
#3
$10.2M666%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$2M130%N/AN/A
#6
$7.6M49-2%N/AN/A
#7
$0.8M5-17%N/AN/A
#8
$7.9M516%N/AN/A
#9
$37.7M243-2%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is BioCrossroads?

BioCrossroads is a catalyst for life sciences ideas and advances Indiana’s signature strengths in the life sciences by connecting with corporate, academic and philanthropic partners; facilitating investments in promising start ups and building new enterprises; and educating through conferences, reports and market development knowledge. The initiative supports the region's existing research and corporate strengths while encouraging new business development and has formed several new nonprofit organizations, including Indiana Health Information Exchange, BioCrossroadsLINX, OrthoWorx, Datalys Center and the Indiana Biosciences Research Institute.

keywords:N/A

N/A

Total Funding

16

Number of Employees

$2.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M16-41%N/A
#2
$1.4M16-11%N/A
#3
$1.7M16-30%N/A
#4
$1.4M16N/AN/A
#5
$1.4M160%N/A